Chairman
McLean Hospital

David Barlow is chairman of McLean Hospital, a global leader in psychiatric treatment, research, and education. He is also the former chairman and CEO of Molecular Insight Pharmaceuticals Inc., a biopharmaceutical company focused on developing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics for cancer.

With more than 30 years of service in the global biopharmaceutical industry, Mr. Barlow has focused on building high-performance companies that develop and market novel products in the U.S. and international markets. Mr. Barlow was previously president, pharmaceuticals, Sepracor Inc. and led the turnaround of Rhone-Poulenc Rorer’s global Armour Pharmaceutical Division. He also has held management positions in business development, planning, and marketing for Rorer Group, Pfizer Inc., and the ARES Serono Group.

Mr. Barlow serves on the president’s council at Massachusetts General Hospital (MGH) and on the advisory boards of several research centers within the MGH family, including the Stoeckle Center and Think:Kids. He also is a member of Vanderbilt University’s Technology Transfer Advisory Committee.

Mr. Barlow earned his MBA from the Stanford Graduate School of Business and his BA from Bates College.